Literature DB >> 10742244

Compatible-solute-supported periplasmic expression of functional recombinant proteins under stress conditions.

S Barth1, M Huhn, B Matthey, A Klimka, E A Galinski, A Engert.   

Abstract

The standard method of producing recombinant proteins such as immunotoxins (rITs) in large quantities is to transform gram-negative bacteria and subsequently recover the desired protein from inclusion bodies by intensive de- and renaturing procedures. The major disadvantage of this technique is the low yield of active protein. Here we report the development of a novel strategy for the expression of functional rIT directed to the periplasmic space of Escherichia coli. rITs were recovered by freeze-thawing of pellets from shaking cultures of bacteria grown under osmotic stress (4% NaCl plus 0.5 M sorbitol) in the presence of compatible solutes. Compatible solutes, such as glycine betaine and hydroxyectoine, are low-molecular-weight osmolytes that occur naturally in halophilic bacteria and are known to protect proteins at high salt concentrations. Adding 10 mM glycine betaine for the cultivation of E. coli under osmotic stress not only allowed the bacteria to grow under these otherwise inhibitory conditions but also produced a periplasmic microenvironment for the generation of high concentrations of correctly folded rITs. Protein purified by combinations of metal ion affinity and size exclusion chromatography was substantially stabilized in the presence of 1 M hydroxyecotine after several rounds of freeze-thawing, even at very low protein concentrations. The binding properties and cytotoxic potency of the rITs were confirmed by competitive experiments. This novel compatible-solute-guided expression and purification strategy might also be applicable for high-yield periplasmic production of recombinant proteins in different expression systems.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742244      PMCID: PMC92025          DOI: 10.1128/AEM.66.4.1572-1579.2000

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  35 in total

1.  Shedding of the soluble form of CD30 from the Hodgkin-analogous cell line L540 is strongly inhibited by a new CD30-specific antibody (Ki-4).

Authors:  O Horn-Lohrens; M Tiemann; H Lange; J Kobarg; M Hafner; H Hansen; W Sterry; R M Parwaresch; H Lemke
Journal:  Int J Cancer       Date:  1995-02-08       Impact factor: 7.396

2.  Diabodies: small bispecific antibody fragments.

Authors:  P Holliger; G Winter
Journal:  Cancer Immunol Immunother       Date:  1997 Nov-Dec       Impact factor: 6.968

Review 3.  Back to log phase: sigma S as a global regulator in the osmotic control of gene expression in Escherichia coli.

Authors:  R Hengge-Aronis
Journal:  Mol Microbiol       Date:  1996-09       Impact factor: 3.501

Review 4.  Osmoadaptation in bacteria.

Authors:  E A Galinski
Journal:  Adv Microb Physiol       Date:  1995       Impact factor: 3.517

5.  Selection and rapid purification of murine antibody fragments that bind a transition-state analog by phage display.

Authors:  J McCafferty; K J Fitzgerald; J Earnshaw; D J Chiswell; J Link; R Smith; J Kenten
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

6.  Purification and characterization of recombinant pea-seed ferritins expressed in Escherichia coli: influence of N-terminus deletions on protein solubility and core formation in vitro.

Authors:  O Van Wuytswinkel; G Savino; J F Briat
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

7.  Single-step purification of a bacterially expressed antibody Fv fragment by immobilized metal affinity chromatography in the presence of betaine.

Authors:  L O Essen; A Skerra
Journal:  J Chromatogr A       Date:  1993-12-24       Impact factor: 4.759

8.  CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.

Authors:  S Barth; B Matthey; M Huhn; V Diehl; A Engert
Journal:  Cytokines Cell Mol Ther       Date:  1999-06

9.  A deletion mutant of Pseudomonas exotoxin-A fused to recombinant human interleukin-9 (rhIL-9-ETA') shows specific cytotoxicity against IL-9-receptor-expressing cell lines.

Authors:  A Klimka; S Barth; S Drillich; W Wels; J van Snick; J C Renauld; H Tesch; H Bohlen; V Diehl; A Engert
Journal:  Cytokines Mol Ther       Date:  1996-09

10.  Cloning, expression and characterization of the Fv fragments of the anti-carbohydrate mAbs B1 and B5 as single-chain immunotoxins.

Authors:  I Benhar; I Pastan
Journal:  Protein Eng       Date:  1994-12
View more
  41 in total

1.  Selective and efficient extraction of recombinant proteins from the periplasm of Escherichia coli using low concentrations of chemicals.

Authors:  Reza Jalalirad
Journal:  J Ind Microbiol Biotechnol       Date:  2013-07-18       Impact factor: 3.346

2.  Identification of opsA, a gene involved in solute stress mitigation and survival in soil, in the polycyclic aromatic hydrocarbon-degrading bacterium Novosphingobium sp. strain LH128.

Authors:  Tekle Tafese Fida; Philip Breugelmans; Rob Lavigne; Jan Roelof van der Meer; René De Mot; Pierre-Joseph Vaysse; Dirk Springael
Journal:  Appl Environ Microbiol       Date:  2014-03-21       Impact factor: 4.792

3.  A human recombinant autoantibody-based immunotoxin specific for the fetal acetylcholine receptor inhibits rhabdomyosarcoma growth in vitro and in a murine transplantation model.

Authors:  S Gattenlöhner; H Jörissen; M Huhn; A Vincent; D Beeson; S Tzartos; A Mamalaki; B Etschmann; H K Muller-Hermelink; E Koscielniak; S Barth; A Marx
Journal:  J Biomed Biotechnol       Date:  2010-02-24

4.  Stabilization of dry protein coatings with compatible solutes.

Authors:  Manuela S Killian; Adam J Taylor; David G Castner
Journal:  Biointerphases       Date:  2018-06-29       Impact factor: 2.456

5.  Structural determinants of the β-selectivity of a bacterial aminotransferase.

Authors:  Gjalt G Wybenga; Ciprian G Crismaru; Dick B Janssen; Bauke W Dijkstra
Journal:  J Biol Chem       Date:  2012-06-28       Impact factor: 5.157

6.  In vitro effects and ex vivo binding of an EGFR-specific immunotoxin on rhabdomyosarcoma cells.

Authors:  Judith Niesen; Hannes Brehm; Christoph Stein; Nina Berges; Alessa Pardo; Rainer Fischer; Andre Ten Haaf; Stefan Gattenlöhner; Mehmet K Tur; Stefan Barth
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-30       Impact factor: 4.553

Review 7.  Amyloid beta-protein assembly as a therapeutic target of Alzheimer's disease.

Authors:  Ghiam Yamin; Kenjiro Ono; Mohammed Inayathullah; David B Teplow
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

8.  Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies.

Authors:  Smita Raghava; Bipasha Barua; Pradeep K Singh; Mili Das; Lalima Madan; Sanchari Bhattacharyya; Kanika Bajaj; B Gopal; Raghavan Varadarajan; Munishwar N Gupta
Journal:  Protein Sci       Date:  2008-09-09       Impact factor: 6.725

9.  Fully human MAP-fusion protein selectively targets and eliminates proliferating CD64(+) M1 macrophages.

Authors:  Dmitrij Hristodorov; Radoslav Mladenov; Rainer Fischer; Stefan Barth; Theo Thepen
Journal:  Immunol Cell Biol       Date:  2016-01-08       Impact factor: 5.126

10.  Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli.

Authors:  Ario de Marco
Journal:  Microb Cell Fact       Date:  2009-05-14       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.